Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Shares Up 1% – Here’s Why

Fidelity Disruptive Medicine ETF (NASDAQ:FMED)’s stock price traded up 1% during mid-day trading on Tuesday . The company traded as high as $26.57 and last traded at $26.38. 10,504 shares were traded during trading, a decline of 16% from the average session volume of 12,565 shares. The stock had previously closed at $26.12.

Fidelity Disruptive Medicine ETF Stock Up 1.0%

The company has a market cap of $60.67 million, a P/E ratio of 41.33 and a beta of 0.82. The stock has a 50 day moving average price of $25.16 and a two-hundred day moving average price of $25.87.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in FMED. Jane Street Group LLC grew its stake in shares of Fidelity Disruptive Medicine ETF by 95.4% in the fourth quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after acquiring an additional 44,630 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its position in Fidelity Disruptive Medicine ETF by 4.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock worth $19,712,000 after acquiring an additional 31,629 shares during the period. BXM Wealth LLC acquired a new stake in Fidelity Disruptive Medicine ETF in the 4th quarter worth about $243,000. Vise Technologies Inc. acquired a new stake in Fidelity Disruptive Medicine ETF in the 4th quarter worth about $234,000. Finally, Virtu Financial LLC acquired a new stake in Fidelity Disruptive Medicine ETF in the 4th quarter worth about $228,000.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.